Clinical Correlates of <i>NRAS</i> and <i>BRAF</i> Mutations in Primary Human Melanoma

Abstract

Distinct clinical phenotypes exist for melanomas bearing NRAS and BRAF mutations, whether considered together or separately, and are associated with features known to predict aggressive tumor behavior. The impact of these mutations is most evident at earlier stages of disease progression.